1. Home
  2. INSP vs FSK Comparison

INSP vs FSK Comparison

Compare INSP & FSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INSP
  • FSK
  • Stock Information
  • Founded
  • INSP 2007
  • FSK 2007
  • Country
  • INSP United States
  • FSK United States
  • Employees
  • INSP N/A
  • FSK N/A
  • Industry
  • INSP Medical/Dental Instruments
  • FSK Investment Managers
  • Sector
  • INSP Health Care
  • FSK Finance
  • Exchange
  • INSP Nasdaq
  • FSK Nasdaq
  • Market Cap
  • INSP 3.8B
  • FSK 4.3B
  • IPO Year
  • INSP 2018
  • FSK N/A
  • Fundamental
  • Price
  • INSP $115.12
  • FSK $15.68
  • Analyst Decision
  • INSP Buy
  • FSK Hold
  • Analyst Count
  • INSP 16
  • FSK 7
  • Target Price
  • INSP $139.40
  • FSK $17.93
  • AVG Volume (30 Days)
  • INSP 1.3M
  • FSK 2.5M
  • Earning Date
  • INSP 11-03-2025
  • FSK 11-05-2025
  • Dividend Yield
  • INSP N/A
  • FSK 17.93%
  • EPS Growth
  • INSP 34.77
  • FSK N/A
  • EPS
  • INSP 1.48
  • FSK 0.97
  • Revenue
  • INSP $882,622,000.00
  • FSK $1,578,000,000.00
  • Revenue This Year
  • INSP $14.83
  • FSK N/A
  • Revenue Next Year
  • INSP $14.44
  • FSK N/A
  • P/E Ratio
  • INSP $60.88
  • FSK $16.08
  • Revenue Growth
  • INSP 16.81
  • FSK N/A
  • 52 Week Low
  • INSP $70.77
  • FSK $14.05
  • 52 Week High
  • INSP $216.01
  • FSK $24.10
  • Technical
  • Relative Strength Index (RSI)
  • INSP 79.74
  • FSK 57.06
  • Support Level
  • INSP $81.79
  • FSK $15.13
  • Resistance Level
  • INSP $92.01
  • FSK $15.72
  • Average True Range (ATR)
  • INSP 4.47
  • FSK 0.35
  • MACD
  • INSP 2.14
  • FSK 0.05
  • Stochastic Oscillator
  • INSP 98.93
  • FSK 72.07

About INSP Inspire Medical Systems Inc.

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

About FSK FS KKR Capital Corp.

FS KKR Capital Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The company's investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation. The company's portfolio is comprised of investments in senior secured loans and second lien secured loans of private middle market U.S. companies and, to a lesser extent, subordinated loans and certain asset-based financing loans of private U.S. companies.

Share on Social Networks: